Impact of ribavirin dose reduction on the efficacy of pegylated interferon plus ribavirin combination therapy for elderly patients infected with genotype 1b and high viral loads-Reference-Cited by-同舟云学术

Impact of ribavirin dose reduction on the efficacy of pegylated interferon plus ribavirin combination therapy for elderly patients infected with genotype 1b and high viral loads

Published:2011-06-28 Issue:7 Volume:41 Page:626-634
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:

Author:

Kohno Hiroshi,Kouno Hirotaka,Aimitsu Shiomi,Aisaka Yasuyuki,Kitamoto Mikiya,Kawakami Hiroiku,Chayama Kazuaki

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1872-034X.2011.00811.x/fullpdf

Reference44 articles.

1. Hepatitis C;Di Bisceglie;Lancet,1998

2. Trends of hepatitis virus carriers;Yoshizawa;Hepatol Res,2002

3. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus;Kiyosawa;Hepatology,1990

4. Natural history of chronic hepatitis C;Seef;Hepatology,2002

5. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial;Manns;Lancet,2001

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors for dose reduction of antiviral therapy in older patients infected with hepatitis C virus: a meta-regression analysis;European Journal of Clinical Microbiology & Infectious Diseases;2013-11-06

2. A Chronic Subdural Hematoma in a Patient Receiving Combination Therapy with Pegylated Interferon Alfa-2b and Ribavirin for Chronic Hepatitis C;Internal Medicine;2013